The Overactive Bladder Treatment Market development is reshaping the landscape of urological therapeutics and patient care. As traditional anticholinergic therapies face limitations in tolerability and cognitive side effects, newer treatment modalities offer a revolutionary alternative. The market, valued at USD 2.934 billion in 2025, is expected to witness steady growth through 2035. Factors...